Investors
News & Events
Contact Us
Home
Who We Are
Company Overview
Management Team
Board of Directors
Partners
Pipeline
Clinical Programs
IRAK1/4
RIPK1
Partnered Programs
Clinical Trials
Investigator Sponsored Research
Expanded Access Policy
Products
Join Our Team
Life at Rigel
Our Values
Benefits
Current Openings
Investors
News & Events
Contact Us
News & Events
Investors
Investors
Overview
News & Events
Press Releases
Events & Presentations
Email Alerts
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
FAQ
Stock Data
Quote
Charts
Historical Data
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Analyst Coverage
Governance
Management Team
Board of Directors
Board Committees
Governance Documents
ESG
News & Events
Press Releases
Events & Presentations
Email Alerts
Recent News
View All News
Jan 13, 2025 8:05am EST
Rigel Provides Business Update and 2025 Outlook
Jan 9, 2025 8:05am EST
Rigel Announces R289 Granted Orphan Drug Designation by the FDA for MDS
View All News
Corporate Presentation
January 2025
Recent Events
View All Events
Jan 16, 2025 11:15 am EST
43rd Annual J.P. Morgan Healthcare Conference
Dec 7 – Dec 10, 2024
66th American Society of Hematology Annual Meeting and Exposition
View IR Calendar
Sign Up for Email Alerts
Receive updates straight into your inbox
Sign up today
Email Alerts
RSS News Feed